Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| RNA polymerase | R-HSA-73864 | map03020 | 6-azathymine | 70269 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | 6-azathymine | 70269 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | 6-azathymine | 70269 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | 6-azathymine | 70269 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | 6-azathymine | 70269 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | omeprazole | 4594 | drug-path |
| Homologous recombination | R-HSA-5685942 | map03440 | omeprazole | 4594 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | omeprazole | 4594 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | omeprazole | 4594 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | omeprazole | 4594 | drug-path |
| Thyroid cancer | R-HSA-9700206 | map05216 | omeprazole | 4594 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | omeprazole | 4594 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | omeprazole | 4594 | drug-path |
| Endometrial cancer | R-HSA-2077421 | map05213 | omeprazole | 4594 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | omeprazole | 4594 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | LM-1685 | 6032 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | LM-1685 | 6032 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | LM-1685 | 6032 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | LM-1685 | 6032 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | LM-1685 | 6032 | drug-path |